A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Related studies linked through entity extraction aliases.